Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease” by…

Overview of attention for article published in Frontiers in Pharmacology, June 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 6 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 12,167 followers.

RT @GriacG: New Open Access article: 'Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important…

06 Sep 2020

Reply Repost Favourite

New Research: Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease” by Dankers M et al. in Frontiers in… https://t.co/1

06 Jul 2020

Reply Repost Favourite

RT @GriacG: New Open Access article: 'Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important…

11 Jun 2020

Reply Repost Favourite

RT @GriacG: New Open Access article: 'Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important…

08 Jun 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.